Martin Mattingly
Director/Board Member at TRACON PHARMACEUTICALS, INC.
Net worth: 341 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Charles Theuer | M | 60 | 20 years | |
| John Bencich | M | 47 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 10 years |
| Stephen Worland | M | 66 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 23 years |
| Jerry Wan | M | 42 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 13 years |
| Jaime Xinos | F | - |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 7 years |
| Douglas Lankler | M | 58 | 25 years | |
| Scott Brown | M | 43 | 9 years | |
| Anthony Clarke | M | 68 | 9 years | |
| Lisa Johnson-Pratt | M | 60 | 3 years | |
| Thomas Sellig | M | 57 | 1 years | |
| Bridget Martell | M | 58 | 4 years | |
| Richard Stewart | M | 65 | 9 years | |
| Saundra Pelletier | F | 54 | 4 years | |
| Stuart Duty | M | 59 | 1 years | |
| Carol Lam | F | 64 | 3 years | |
| William LaRue | M | 73 | 10 years | |
| Rainer Twiford | M | 71 | 16 years | |
| Thomas King | M | 69 | 1 years | |
| James L. Freddo | M | 69 | 8 years | |
| Vaughn Himes | M | 63 | 2 years | |
| Brenda Marczi | F | - | 3 years | |
| Suneet Varma | M | 55 | 23 years | |
| Payal Sahni Becher | F | - | 27 years | |
| Mike McDermott | M | 58 | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Daniel Cormack | M | 59 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 26 years |
| Michelle Burris | F | 58 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 9 years |
| Henry McKinnell | M | 81 | 8 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| Cameron Lawrence | M | 44 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 4 years |
| Jack Goldstein | M | 77 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 7 years |
| James R. Thomas | M | 73 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 5 years |
| George A. Lorch | M | 82 | 15 years | |
| Andrew L. Graham | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 7 years |
| Siegfried Reich | M | 64 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 17 years |
| Wyllie Cornwell | M | 76 | 23 years | |
| Karen Potts | M | 61 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 7 years |
| AnnKatrin Petersen-Jappelli | M | - |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | - |
| Michael R. Jirousek | M | 65 | 5 years | |
| E. Lawrence Hill | M | 73 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 1 years |
| Allan P. Marchington | M | 56 | - | |
| Alfred Scheidegger | M | 67 | 2 years | |
| Bonne Adams | F | 47 | 17 years | |
| Sharon Real | M | 60 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 12 years |
| Paul Fitzhenry | M | 63 | 4 years | |
| John W. Poyhonen | M | 64 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 7 years |
| David Smith | M | 64 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Ted Wang | M | 57 | 1 years | |
| Douglas D. Durbin | M | - |
University of Kentucky
| 7 years |
| Joseph M. Danis | M | - | 10 years | |
| Kenji Harada | M | 64 | 4 years | |
| Jaime Welch | F | - |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | - |
| Everett Cunningham | M | 57 | 9 years | |
| Jonathan Emms | M | - | 20 years | |
| Patricia L. Bitar | F | 65 | 4 years | |
| Michelle Griffin | F | 58 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | 5 years |
| Jennifer Schroeder | F | - | 20 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Susie Melody | F | - |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 4 years |
| Mark Wiggins | M | 68 | 4 years | |
| William E. Dorris | M | - |
University of Kentucky
| 7 years |
| H. Leon Shadowen | M | - |
University of Kentucky
| 2 years |
| Donald D. Tartre | M | 64 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 4 years |
| Robert N. Burt | M | 86 | 11 years | |
| Franklin Raines | M | 74 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| Hironori Hozoji | M | 63 | 4 years | |
| Michael Brown | M | 82 | 16 years | |
| Peter Corr | M | 76 | 6 years | |
| Dana George Mead | M | 88 | 12 years | |
| Jay Moyes | M | 70 | 6 years | |
| H. Parker | F | 68 | 11 years | |
| George Milne | M | 80 | 32 years | |
| Peter Johnson | M | 78 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 16 years |
| Olivier Brandicourt | M | 68 | 13 years | |
| Donald W. Reid | M | - |
University of Kentucky
| 7 years |
| Frank J. Sardone | M | - |
University of Kentucky
| 6 years |
| Donald Joseph | M | 70 | 6 years | |
| Stephen W. Kaldor | M | 62 | 3 years | |
| Caroline Loewy | F | 58 | 26 years | |
| Michael Marberry | M | 65 |
University of Kentucky
| 4 years |
| Jonathan White | M | 64 | 10 years | |
| Lynne E. Weissberger | M | - | 7 years | |
| William J. Robison | M | 88 | 40 years | |
| William J. Creelman | M | 69 | 1 years | |
| David Booth | M | - | - | |
| Shankar Musunuri | M | 60 | 14 years | |
| Mariano García-Valiño | M | 58 | 8 years | |
| Ying Song | F | - | 13 years | |
| Beth Anne Piper | M | - | 3 years | |
| Randall Kaja | M | - | 15 years | |
| Elna van der Ryst | F | - | 11 years | |
| Carol Szeto | F | - | 6 years | |
| William R. Howell | M | 88 | 9 years | |
| Scott Kay | M | - | 7 years | |
| Thomas J. Joyce | M | 64 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | 6 years |
| Fei He | M | 55 | 7 years | |
| Robert Karr | M | 75 | 4 years | |
| Malvina Laudicina | F | 65 | 5 years | |
| Liam Ratcliffe | M | 60 | 12 years | |
| Shaun Stewart | M | - | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 89 | 89.00% |
| Canada | 15 | 15.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Mattingly
- Personal Network
